1517 / 1544
Cattaneo
Radiot
Oncol
2008
13 pts
PTV 215-
745cc
PTV95%:
3D vs TOMO
92% vs 97.2%
(p<0.01)
Dose distribution:
3D vs TOMO
2.4 vs 1.4 (p<0.01)
(TOMO benefit 42%)
Rousseau
Cancer
Radioth
2012
10 pts
PTV 723
(392-885
cc)
Conformity index:
3D 0.55±0.07 vs VMAT 0.89±0.07
(VMAT benefit 60%)
3D vs VMAT-TOMO: PTV